Simon Borg‐Bartolo

Precision medicine in inflammatory bowel disease: concept, progress and challenges

Simon Borg‐Bartolo, Ray Boyapati, Jack Satsangi et al. · F1000Research · 2020 · 88 citations · Full text

Medicine, Biomedical Sciences, Immunology +17

Comparative Proteomic Analysis of Supportive and Unsupportive Extracellular Matrix Substrates for Human Embryonic Stem Cell Maintenance

Despina Soteriou, Banu İskender, Adam Byron et al. · Journal of Biological Chemistry · 2013 · 58 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study

Shaji Sebastian, G Walker, Nicholas A. Kennedy et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 38 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II

Marco Vincenzo Lenti, Vivien Dolby, Tanya Clark et al. · Alimentary Pharmacology & Therapeutics · 2021 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Implications for sequencing of biologic therapy and choice of second <scp>anti‐TNF</scp> in patients with inflammatory bowel disease: results from the <scp>IMmunogenicity</scp> to Second <scp>Anti‐TNF</scp> therapy (<scp>IMSAT</scp>) therapeutic drug monitoring study

Neil Chanchlani, Simeng Lin, Marcus Auth et al. · Alimentary Pharmacology & Therapeutics · 2022 · 17 citations · Full text

Life Sciences, Immunology, Pharmacology +16